Epirubicin Hydrochloride |
|
|---|---|
| Category : | API |
| CAS No. : | 56390-09-1 |
| Synonyms : | Farmorubicin; Pharmorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Hydrochloride; (8S-cis)-4'-Epidoxorubicin Hydrochloride; 4'-epi-Adriamycin Hydrochloride; Ellence; Epidoxorubicin Hydrochloride; |
| Mol. Formula : | C27H29NO11·HCI |
| Assay : | 97.0% to 102.0% (on anhydrous basis) |
| Specification : | USP/EP/BP |
| Certificates and Documents : | GMP/FDA/CEP/DMF |
| Appearance : | Orange-red powder |
| Grade : | Pharma grade |
| Application : | Epirubicin Hydrochloride is used to treat breast cancer. It is used after surgeryin patients whose cancerhas spread to the lymph nodesunder the arm. Epirubicin Hydrochloride is also being studied in the treatment of other types of cancer. |
| Packaging Details : | 500g/Bottle |
| Delivery time : | 1-2 weeks |
| Storage : | In an airtight container, protected from light, at a temperature of 2℃ to 8℃ |
| Shelf life : | 2 Year |